Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: Clin Pharmacol Ther. 2022 Feb 8;112(5):959–967. doi: 10.1002/cpt.2526

Table 1.

Assignment of Predicted CYP2C19 Phenotype Based on Genotype

Predicted phenotype Genotype Examples of CYP2C19
diplotypesa
CYP2C19 ultrarapid metabolizer An individual carrying two increased function alleles *17/*17
CYP2C19 rapid metabolizer An individual carrying one normal function allele and one increased function allele *1/*17
CYP2C19 normal metabolizer An individual carrying two normal function alleles *1/*1
CYP2C19 likely intermediate metabolizerb An individual carrying one normal function allele and one decreased function allele or one increased function allele and one decreased function allele or two decreased function alleles *1/*9, *9/*17, *9/*9
CYP2C19 intermediate metabolizer An individual carrying one normal function allele and one no function allele or one increased function allele and one no function allele *1/*2, *1/*3, *2/*17, *3/*17
CYP2C19 likely poor metabolizerb An individual carrying one decreased function allele and one no function allele *2/*9, *3/*9
CYP2C19 poor metabolizer An individual carrying two no function alleles *2/*2, *3/*3, *2/*3
Indeterminate An individual carrying one or two uncertain function alleles *1/*12, *2/*12, *12/*14
a

Please refer to the CYP2C19 Diplotype-Phenotype Table online for a complete list. For allele functions and population-specific allele and phenotype frequencies, please refer to the CYP2C19 Allele Functionality Table and the CYP2C19 Allele Frequency Table online (8, 9).

b

There are limited data to characterize the function of decreased function alleles.